Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 1;23(1):29-38.
doi: 10.1080/19585969.2022.2042164. eCollection 2021.

Neurocognitive functioning in bipolar disorder: What we know and what we don't

Kamyar Keramatian  1 , Ivan J Torres  1 , Lakshmi N Yatham  1
Affiliations
Review

Neurocognitive functioning in bipolar disorder: What we know and what we don't

Kamyar Keramatian et al. Dialogues Clin Neurosci. .

Abstract

Introduction: This narrative review of systematic reviews and meta-analyses aims at compiling available evidence in various aspects of neurocognitive functioning in Bipolar Disorder (BD). Methods: We conducted a MEDLINE literature search and identified 38 relevant systematic reviews and metaanalyses. Results: Current evidence suggests that BD is associated with cognitive impairment across multiple domains and during all clinical states. However, there is a considerable cognitive heterogeneity within BD, which cannot be explained by clinical subtypes, and the pattern of neurocognitive impairment in BD overlaps with other psychiatric conditions such as major depression and schizophrenia. Residual depressive symptoms, poor clinical course and higher number of manic episodes may negatively impact cognitive performance, which is a major predictor of general functioning in BD. Evidence from available prospective studies does not support the notion of progressive cognitive decline in BD while some evidence exists to suggest patients may show some improvements in cognitive functioning following the first manic episode. Furthermore, a subset of patients may show premorbid cognitive abnormalities that could signal an early neurodevelopmental aetiology. Preliminary findings from small studies identify potential pro-cognitive effects of Cognitive Remediation, erythropoietin, intranasal insulin, lurasidone, mifepristone, repetitive Transcranial Magnetic Stimulation and transcranial Direct Current Stimulation in BD. Discussion: Longitudinal studies in high-risk individuals can provide a better understanding of the development and progression of neurocognitive impairment in BD. Largescale randomised control trials are needed to compare the pro-cognitive efficacy of various pharmacological and non-pharmacological interventions in different cognitive subgroups of patients at different stages of BD.

Keywords: Bipolar disorder; meta-review; neurocognitive functioning.

PubMed Disclaimer

Conflict of interest statement

IJT has been serving as a consultant for Community Living British Columbia. LNY has been on speaker/advisory boards for, or has received research grants from Alkermes, AstraZeneca, Bristol Myers Squibb, CANMAT, CIHR, DSP, Eli Lilly, GlaxoSmithKline, Janssen, the Michael Smith Foundation for Health Research, Pfizer, Servier, Sunovion, and the Stanley Foundation.

References

    1. Abramovitch A, Short T, Schweiger A.. 2021. The C factor: Cognitive dysfunction as a transdiagnostic dimension in psychopathology. Clin Psychol Rev. 86:102007. - PubMed
    1. Baune BT, Malhi GS.. 2015. A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder. Bipolar Disord. 17(Suppl 2):41–55. - PubMed
    1. Bernabei L, Bersani FS, Pompili E, Delle Chiaie R, Valente D, Corrado A, Vergnani L, Ferracuti S, Biondi M, Coccanari de'Fornari MA.. 2020. Cognitive remediation for the treatment of neuropsychological disturbances in subjects with euthymic bipolar disorder: Findings from a controlled study. J Affect Disord. 273:576–585. - PubMed
    1. Bersani FS, Minichino A, Bernabei L, Spagnoli F, Corrado A, Vergnani L, Mannarelli D, Pauletti C, Fattapposta F, Biondi M, et al. . 2017. Prefronto-cerebellar tDCS enhances neurocognition in euthymic bipolar patients. Findings from a placebo-controlled neuropsychological and psychophysiological investigation. J Affect Disord. 209:262–269. - PubMed
    1. Bora E. 2016. Differences in cognitive impairment between schizophrenia and bipolar disorder: Considering the role of heterogeneity. Psychiatry Clin Neurosci. 70(10):424–433. - PubMed